Gastrointestinal Cancer

Latest News

Anatomical image of a pancreas with tumors
Atebimetinib Combo Shows Survival Signal in First-Line Pancreatic Cancer

June 22nd 2025

The novel MEK inhibitor atebimetinib plus chemotherapy showed early signs of survival benefit in first-line treatment of patients with pancreatic cancer.

Illustration of a pancreas on a blue background
Novel ADC Receives FDA Fast Track Designation for Pancreatic Cancer

May 30th 2025

Anatomical rendering of the human body with the colon highlighted
Panitumumab Improves Outcomes in RAS/BRAF Wildtype Colon Cancer

May 22nd 2025

Graphic reading "FDA APPROVED" resembling a seal of approval
Retifanlimab Receives FDA Approval for Advanced Anal Cancer

May 15th 2025

pancreatic ductal adenocarcinoma
Proactive Management of NALIRIFOX-Related Diarrhea Is Crucial in Metastatic PDAC

April 12th 2025

Latest CME Events & Activities

Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma

View More

Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma

View More

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

View More

Medical Crossfire®: Integrating Next-Generation Endocrine Targeting Therapies to Improve Outcomes for Patients With HR+/HER2- Breast Cancer

View More

GI Tumor Board—Applying Recent Advances in Biomarker Testing and Treatment in Metastatic Colorectal Cancer

View More

Medical Crossfire®: Improving Patient Outcomes in Myeloproliferative Neoplasms With Novel Therapeutic Approaches

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

Community Practice Connections™: 14th Asia-Pacific Primary Liver Cancer Expert Meeting

View More

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?

View More

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

View More

Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care

View More

2nd Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

Show Me the Data™: Bridging Clinical Gaps Along the Continuum From Resectable, Early Stage to Advanced Gastric/Gastroesophageal Junction Cancers

View More

19th Annual New York GU Cancers Congress™

March 13-14, 2026

Register Now!

Medical Crossfire®: Expert Interpretations of the Latest Data in CLL Management – Understanding the Impact of Optimal Treatment Selection on Patient Outcomes

View More

Addressing Unmet Needs in HER2+ Metastatic BTC

View More

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

View More

From Bench to Bedside: Paradigm Shifts in HER2+ Metastatic BTC Treatment

View More

Proactive Adverse Event Management for HER2+ BTC Treatments

View More